Market Place
Sourcing Support
All News #Library
Biotech
New BIMZELX® Data at ACR 2024 on Psoriatic Arthritis Treatment
14 Nov 2024 //
PR NEWSWIRE
UCB & Biogen’s dapirolizumab pegol paves path for lupus treatment
13 Nov 2024 //
EXPRESSPHARMA
UCB`s tau drug flunks Alzheimer`s trial days after Roche`s exit
01 Nov 2024 //
FIERCE BIOTECH
Positive Ph3 Results For UCB/Biogen`s Dapirolizumab Pegol
07 Oct 2024 //
PR NEWSWIRE
UCB Announces Two-Year Data For Bimzelx In Hidradenitis At EADV
27 Sep 2024 //
PR NEWSWIRE
UCB Presents 4-Year Bimzelx Data At EADV 2024
25 Sep 2024 //
PR NEWSWIRE
Ucb Bimzelx® Hs Phase 3 Published: The Lancet Hidradenitis Data Release
23 May 2024 //
PR NEWSWIRE
FDA reviews UCB psoriasis drug after manufacturing inspection
20 Sep 2023 //
FIERCE PHARMA
UCB touts new data for bimekizumab in hidradenitis suppurativa
20 Mar 2023 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.